BMO Capital Initiates Coverage On Evolent Health with Outperform Rating, Announces Price Target of $7
Benzinga Newsdesk 12 months ago
NewsPrice TargetInitiationAnalyst Ratings
BMO Capital analyst Sean Dodge initiates coverage on Evolent Health (NYSE:EVH) with a Outperform rating and announces Price Target of $7.
BMO Capital analyst Sean Dodge initiates coverage on Evolent Health (NYSE:EVH) with a Outperform rating and announces Price Target of $7.